120 related articles for article (PubMed ID: 7896657)
21. Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
Symons FJ; Sutton KA; Bodfish JW
Am J Ment Retard; 2001 Jul; 106(4):336-43. PubMed ID: 11414874
[TBL] [Abstract][Full Text] [Related]
22. Role for opioid peptides in self-injurious behavior: dissociation from autonomic nervous system functioning.
Herman BH; Hammock MK; Egan J; Arthur-Smith A; Chatoor I; Werner A
Dev Pharmacol Ther; 1989; 12(2):81-9. PubMed ID: 2714161
[TBL] [Abstract][Full Text] [Related]
23. Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients.
Barron J; Sandman CA
Am J Ment Defic; 1983 Sep; 88(2):177-86. PubMed ID: 6638079
[TBL] [Abstract][Full Text] [Related]
24. A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders.
Matson JL; Lovullo SV
Behav Modif; 2008 Jan; 32(1):61-76. PubMed ID: 18096972
[TBL] [Abstract][Full Text] [Related]
25. Risperidone-induced double incontinence.
Hergüner S; Mukaddes NM
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
[No Abstract] [Full Text] [Related]
26. Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
Taylor DV; Hetrick WP; Neri CL; Touchette P; Barron JL; Sandman CA
Pharmacol Biochem Behav; 1991 Sep; 40(1):79-82. PubMed ID: 1780350
[TBL] [Abstract][Full Text] [Related]
27. Behavioral assessment and treatment of self-injurious behavior in autism.
Minshawi NF
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):875-86, x. PubMed ID: 18775375
[TBL] [Abstract][Full Text] [Related]
28. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
Gerrits MA; Kuzmin AV; van Ree JM
Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419
[TBL] [Abstract][Full Text] [Related]
29. Naltrexone and fluoxetine in Prader-Willi syndrome.
Benjamin E; Buot-Smith T
J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
[TBL] [Abstract][Full Text] [Related]
31. Further analysis of the relationship between self-injury and self-restraint.
Fisher WW; Grace NC; Murphy C
J Appl Behav Anal; 1996; 29(1):103-6. PubMed ID: 8881349
[TBL] [Abstract][Full Text] [Related]
32. Self-restraint as positive reinforcement for self-injurious behavior.
Smith RG; Lerman DC; Iwata BA
J Appl Behav Anal; 1996; 29(1):99-102. PubMed ID: 8881348
[TBL] [Abstract][Full Text] [Related]
33. Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.
Buzan RD; Dubovsky SL; Treadway JT; Thomas M
Psychiatr Serv; 1995 May; 46(5):511-2. PubMed ID: 7627682
[TBL] [Abstract][Full Text] [Related]
34. Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.
Knabe R; Schulz P; Richard J
J Autism Dev Disord; 1990 Dec; 20(4):591-3. PubMed ID: 2279977
[No Abstract] [Full Text] [Related]
35. Self-injurious behaviour: a comparison of caffeine and pemoline models in rats.
Kies SD; Devine DP
Pharmacol Biochem Behav; 2004 Dec; 79(4):587-98. PubMed ID: 15582667
[TBL] [Abstract][Full Text] [Related]
36. Does functional communication training compete with ongoing contingencies of reinforcement? An analysis during response acquisition and maintenance.
Shirley MJ; Iwata BA; Kahng SW; Mazaleski JL; Lerman DC
J Appl Behav Anal; 1997; 30(1):93-104. PubMed ID: 9157100
[TBL] [Abstract][Full Text] [Related]
37. Naltrexone in young autistic children: replication study and learning measures.
Kolmen BK; Feldman HM; Handen BL; Janosky JE
J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
[TBL] [Abstract][Full Text] [Related]
38. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
Capone GT; Goyal P; Grados M; Smith B; Kammann H
J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
[TBL] [Abstract][Full Text] [Related]
39. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities.
Garber HJ; McGonigle JJ; Slomka GT; Monteverde E
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1157-60. PubMed ID: 1429420
[TBL] [Abstract][Full Text] [Related]
40. On the relationship between self-injurious behavior and self-restraint.
Smith RG; Iwata BA; Vollmer TR; Pace GM
J Appl Behav Anal; 1992; 25(2):433-45. PubMed ID: 1634431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
